Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f(®) in healthy women after follicle-stimulating...

Por Lammerich, Andreas, Mueller, Arnd, Bias, Peter
Publicado no Reprod Biol Endocrinol (2015)

Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assis...

Por Strowitzki, Thomas, Kuczynski, Waldemar, Mueller, Arnd, Bias, Peter
Publicado no Reprod Biol Endocrinol (2016)

Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label...

Por Strowitzki, Thomas, Kuczynski, Waldemar, Mueller, Arnd, Bias, Peter
Publicado no Reprod Biol Endocrinol (2016)

Comment on “Biosimilar FSH preparations- are they identical twins or just siblings?”

Por Strowitzki, Thomas, Kuczynski, Waldemar, Mueller, Arnd, Bias, Peter
Publicado no Reprod Biol Endocrinol (2016)

Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency

Por Winstel, Rainer, Wieland, Juergen, Gertz, Beate, Mueller, Arnd, Allgaier, Hermann
Publicado no Drugs R D (2017)